{"id":"CHEMBL1043","canonicalSmiles":"Nc1ccc(S(=O)(=O)c2ccc(N)cc2)cc1","inchiKey":"MQJKPEGWNLWLTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPSONE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aczone","Dapsone"],"synonyms":["Dapsone","Diaminodiphenylsulfone","Diaphenylsulfone","J04BA02","NSC-6091","NSC-6091D"],"crossReferences":{"DailyMed":["dapsone"],"PubChem":["11112211","124882059","144203922","144208545","144210875","170464895","17389950","26747072","49718182","855979"],"Wikipedia":["Dapsone"],"drugbank":["DB00250"],"chEBI":["4325"]},"count":14,"approvedIndications":["EFO_1000684","EFO_0001054","EFO_0003894"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL1094","canonicalSmiles":"NC(=O)OCC(COC(N)=O)c1ccccc1","inchiKey":"WKGXYQFOCVYPAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FELBAMATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Felbamate","Felbatol","Taloxa"],"synonyms":["ADD-03055","Felbamate","W-554"],"crossReferences":{"DailyMed":["felbamate"],"PubChem":["104171154","11113343","144203696","144212685","170465178","50104096","56422162","855835","90340922"],"Wikipedia":["Felbamate"],"drugbank":["DB00949"],"chEBI":["4995"]},"childChemblIds":["CHEMBL2130858"],"count":2,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000161509","ENSG00000183454","ENSG00000116032","ENSG00000273079","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000474"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for epilepsy and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1163074","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)[C@@H](N)CS)[C@@H](O)[C@H]1O","inchiKey":"FTSDEWPMACCNGN-YTMOPEAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1163074","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02684"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1183605","canonicalSmiles":"CCCCCCCCCCCCCCCC[N+](C)(C)C","inchiKey":"RLGQACBPNDBWTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETRIMONIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetrimonium"],"crossReferences":{"drugbank":["DB01718"],"chEBI":["39561"]},"childChemblIds":["CHEMBL1600855","CHEMBL307346","CHEMBL1895807"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200340","canonicalSmiles":"CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1.O=P(O)(O)O","inchiKey":"PGZUMBJQJWIWGJ-ONAKXNSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OSELTAMIVIR PHOSPHATE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1229","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oseltamivir phosphate","Tamiflu"],"synonyms":["Oseltamivir phosphate","RO 64-0796/002","RO-64-0796-002"],"crossReferences":{"DailyMed":["oseltamivir%20phosphate"],"chEBI":["7799"]},"count":2,"approvedIndications":["EFO_0007328"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and is indicated for influenza and has 1 investigational indication."}
{"id":"CHEMBL1200480","canonicalSmiles":"CC(=O)O.C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O","inchiKey":"XQEJFZYLWPSJOV-XJQYZYIXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE ACETATE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1680","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bynfezia pen","Mycapssa","Octreotide acetate","Octreotide acetate (preservative free)","Octreotide acetate preservative free","Sandostatin","Sandostatin lar"],"synonyms":["Octreotide acetate","SMS 201-995 AC","SMS-201-995 AC","SMS-201995-AC"],"crossReferences":{"DailyMed":["octreotide%20acetate"]},"count":17,"approvedIndications":["EFO_0000616","EFO_1001485"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000132671","ENSG00000278195","ENSG00000139874","ENSG00000180616"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0043579","HP_0002014","EFO_1001901","MONDO_0007254","Orphanet_657","EFO_0003770","EFO_0001073","MONDO_0008315","MONDO_0004565","MONDO_0002691","EFO_1000097","Orphanet_739","EFO_1001485","MONDO_0002120","EFO_0000574","EFO_1000852","EFO_0002626","MONDO_0024880","HP_0002019"],"count":20},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for neoplasm and acromegaly and has 15 investigational indications."}
{"id":"CHEMBL1200647","canonicalSmiles":"CC1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(OC2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)CC(O)C(C(=O)O)C(O)CC(=O)CC(O)CC(O)CC(O)CC(=O)CCCC(=O)CC(=O)OC1C(C)CC(C)C(O)CC(=O)c1ccc(N)cc1","inchiKey":"OPGSFDUODIJJGF-JBUZINEHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANDICIDIN","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vanobid"],"synonyms":["Candicidin"],"crossReferences":{"Wikipedia":["Candicidin"],"drugbank":["DB01152"],"chEBI":["3349"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200651","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O.c1ccc(CNCCNCc2ccccc2)cc1","inchiKey":"JTFXYBGKLCCFSP-LQDWTQKMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN G BENZATHINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bicillin","Bicillin L-A"],"synonyms":["E708"],"crossReferences":{"DrugCentral":["4347"],"Wikipedia":["Benzathine_benzylpenicillin"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200715","canonicalSmiles":"CC(CNC1CCCCC1)OC(=O)c1ccccc1.Cl","inchiKey":"MTFCPNHRBINLRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXYLCAINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1197","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cyclaine"],"synonyms":["Hexylcaine HCl","Hexylcaine hydrochloride"],"crossReferences":{"PubChem":["144204007","170465088","56463225"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200769","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"GGRBYIUPUOYRLQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE CITRATE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tripelennamine citrate"],"crossReferences":{"PubChem":["144205071","170465118","26749792"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948."}
{"id":"CHEMBL1200829","canonicalSmiles":"O=C1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"PHOQVHQSTUBQQK-SQOUGZDYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCONOLACTONE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E575","Gluconolactone"],"crossReferences":{"DailyMed":["gluconolactone"],"PubChem":["144204936","144207627","170465327","26748700"],"Wikipedia":["Glucono_delta-lactone"],"drugbank":["DB04564"],"chEBI":["16217"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL1200870","canonicalSmiles":"CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1.O=C(O)/C=C\\C(=O)O","inchiKey":"WLRMANUAADYWEA-NWASOUNVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMOLOL MALEATE","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL499","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blocadren","Istalol","Timolol maleate","Timoptic","Timoptic Xe","Timoptic in ocudose","Timoptic-xe"],"synonyms":["Timolol hydrogen maleate salt","Timolol maleate","Timolol maleate, s-enantiomer","WP-934"],"crossReferences":{"DailyMed":["timolol%20maleate"],"PubChem":["144212785","56423148","855659","93576681"],"chEBI":["9600"]},"count":7,"approvedIndications":["EFO_0004190","EFO_1001069","EFO_0000516"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591"],"count":2},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_1000879","EFO_1000809","EFO_0000516","EFO_0000666","EFO_1000635"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1200937","canonicalSmiles":"CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12","inchiKey":"SUYRLXYYZQTJHF-VMBLUXKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DALFOPRISTIN","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dalfopristin","RP 54476","RP-54476"],"crossReferences":{"DailyMed":["dalfopristin"],"Wikipedia":["Dalfopristin"],"drugbank":["DB01764"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1999 and has 1 investigational indication."}
{"id":"CHEMBL1200943","drugType":"Small molecule","blackBoxWarning":false,"name":"MERSALYL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Salyrgan"],"synonyms":["Mersalyl","Mersalyl sodium"],"crossReferences":{"DrugCentral":["4657"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200963","canonicalSmiles":"CCNC(=O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1ccccc1","inchiKey":"AQOKCDNYWBIDND-FTOWTWDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIMATOPROST","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bimatoprost","Durysta","Latisse","Lumigan"],"synonyms":["AGN 192024","AGN-192024","Bimatoprost"],"crossReferences":{"DailyMed":["bimatoprost"],"Wikipedia":["Bimatoprost"],"drugbank":["DB00905"],"chEBI":["51230"]},"count":8,"approvedIndications":["EFO_0004190","EFO_1001069","Orphanet_55654","EFO_0000516","MONDO_0003037"],"linkedTargets":{"rows":["ENSG00000122420"],"count":1},"linkedDiseases":{"rows":["HP_0010750","EFO_0004190","EFO_1001069","EFO_0001059","EFO_1001022","EFO_0004192","Orphanet_79364","EFO_1001466","Orphanet_55654","EFO_0004208","EFO_0000516","EFO_0004191","MONDO_0003037"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL1201152","canonicalSmiles":"C=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5.Cl","inchiKey":"GYWMRGWFQPSQLK-OPHZJPRHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NALMEFENE HYDROCHLORIDE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL982","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Revex"],"synonyms":["JF-1 HYDROCHLORIDE","Nalmefene hydrochloride"],"count":1,"linkedTargets":{"rows":["ENSG00000082556","ENSG00000116329","ENSG00000112038"],"count":3},"linkedDiseases":{"rows":["EFO_0003829"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1201204","canonicalSmiles":"Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1","inchiKey":"PWAUCHMQEXVFJR-PMAPCBKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFPIRAMIDE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefpiramide","WY-44,635","WY-44635"],"crossReferences":{"PubChem":["144206001","50112698"],"Wikipedia":["Cefpiramide"],"drugbank":["DB00430"],"chEBI":["59213"]},"childChemblIds":["CHEMBL1200672"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for bacterial disease."}
{"id":"CHEMBL1201659","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENIRAMINE POLISTIREX","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL505","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chlorpheniramine polistirex"],"crossReferences":{"DailyMed":["chlorpheniramine%20polistirex"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984."}
{"id":"CHEMBL1201728","canonicalSmiles":"CN(C)CC(c1ccc(O)cc1)C1(O)CCCCC1.O=C(O)CCC(=O)O","inchiKey":"ORUUBRMVQCKYHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DESVENLAFAXINE SUCCINATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1118","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Desvenlafaxine succinate","Pristiq"],"synonyms":["DVS-233","Desvenlafaxine succinate","Desvenlafaxine succinate anhydrous","Desvenlafaxine succinate hydrate","Desvenlafaxine succinate monohydrate","WY-45233","WY45233"],"crossReferences":{"DailyMed":["desvenlafaxine%20succinate"]},"count":5,"approvedIndications":["MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_1000783","EFO_0005687","MONDO_0002050","MONDO_0002009","EFO_0003761","EFO_1001917","HP_0031217","EFO_0003922"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for major depressive disorder and unipolar depression and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201748","canonicalSmiles":"CO[C@H]1C[C@H]2OC[C@@]2(OC(C)=O)[C@H]2[C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C(C)=C([C@@H](OC)C(=O)[C@]12C)C3(C)C","inchiKey":"BMQGVNUXMIRLCK-OAGWZNDDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CABAZITAXEL","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jevtana","Jevtana kit"],"synonyms":["Cabazitaxel","Cabazitaxel acetonate","TXD 258","TXD-258","XRP 6258","XRP-6258"],"crossReferences":{"Wikipedia":["Cabazitaxel"],"drugbank":["DB06772"],"chEBI":["63584"]},"count":24,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000292","MONDO_0003890","MONDO_0007254","EFO_0003085","EFO_1001951","MONDO_0001056","MONDO_0001657","EFO_0000673","EFO_0008528","EFO_0000196","EFO_0000326","EFO_1001094","EFO_0000616","MONDO_0021656","EFO_0006859","EFO_0005088","EFO_1000601","MONDO_0008170","MONDO_0008315","EFO_0003060","EFO_0001663","EFO_0000311","EFO_0000702","EFO_0006544","EFO_1000796","MONDO_0024880","EFO_0000519","EFO_0000181"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and is indicated for neoplasm and cancer and has 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1213371","canonicalSmiles":"O=C(O)c1cccc(/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2)c1","inchiKey":"TUYDQQMKXSQIQG-GONBZBRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213371","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1222313","canonicalSmiles":"O=C(O)c1ccc(NS(=O)(=O)c2ccsc2C(=O)O)c(O)c1","inchiKey":"RDPXXOOKKRIKFN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1222313","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL122270","canonicalSmiles":"CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1","inchiKey":"MXYUKLILVYORSK-HBMCJLEFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBELINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-Lobeline","Alpha-Lobeline","Alpha-Lobeline HCl","Lobeline","Lobeline hydrochloride"],"crossReferences":{"PubChem":["144204451","26751618","29215024","50104285","90340738"],"drugbank":["DB05137"],"chEBI":["48723"]},"childChemblIds":["CHEMBL1257005"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1229801","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)N1CCC[C@H]1C(=O)NCc1cccc(Cl)c1","inchiKey":"FHVBVJXZKNCSLP-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1229801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06911"]},"childChemblIds":["CHEMBL3422995"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230906","canonicalSmiles":"CC(C)(N)C(=O)O","inchiKey":"FUOOLUPWFVMBKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Alpha-Aminoisobutyric Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alpha-Aminoisobutyric Acid"],"crossReferences":{"drugbank":["DB02952"],"chEBI":["27971"]},"childChemblIds":["CHEMBL1770613"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232157","canonicalSmiles":"CCCCCCCCCC[N+](C)(C)[O-]","inchiKey":"ZRKZFNZPJKEWPC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212550"],"drugbank":["DB02613"],"chEBI":["41899"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234669","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"OVRNDRQMDRJTHS-PVFLNQBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234669","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03740"],"chEBI":["44278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234674","canonicalSmiles":"CC[N+](C)(C)CCCS(=O)(=O)[O-]","inchiKey":"NNCRHRDBFDCWPA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL DIMETHYL AMMONIO PROPANE SULFONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234815","canonicalSmiles":"Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21","inchiKey":"UOKGZPYGRJDACN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234815","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08300"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235782","canonicalSmiles":"CO[C@H]1CCCC[C@@H](c2ccccc2)OC(=O)[C@@H](C)[C@@]2(O)O[C@@H]([C@@H](C)/C=C/[C@H]1OC)[C@@H](C)[C@H](O)[C@H]2OC","inchiKey":"WPMGNXPRKGXGBO-OFQQMTDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SORAPHEN A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02859"],"chEBI":["9200"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1237061","canonicalSmiles":"O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.O=C([O-])C[C@H](O)C[C@H](O)/C=C/c1c(C2CC2)nc2ccccc2c1-c1ccc(F)cc1.[Ca+2]","inchiKey":"RHGYHLPFVJEAOC-FFNUKLMVSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PITAVASTATIN CALCIUM","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201753","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Livalo","Pitavastatin calcium"],"synonyms":["NK-104","Pitavastatin Calcium","Pitavastatin calcium","Pitavastatin calcium salt"],"crossReferences":{"DailyMed":["pitavastatin%20calcium"],"PubChem":["49681579"],"chEBI":["71258"]},"count":3,"approvedIndications":["HP_0003119","EFO_0003774"],"linkedTargets":{"rows":["ENSG00000113161"],"count":1},"linkedDiseases":{"rows":["HP_0003124","HP_0003119","EFO_0003774","Orphanet_309005"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for hyperlipidemia and abnormal circulating lipid concentration and has 1 investigational indication."}
{"id":"CHEMBL1256994","canonicalSmiles":"C[N+](C)(C)CCOP(=O)([O-])OP(=O)([O-])OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@H](O)[C@@H]1O.[Na+]","inchiKey":"YWAFNFGRBBBSPD-OCMLZEEQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CITICOLINE SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1231700","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ceraxon"],"synonyms":["Cdp-cholin","Citicoline","Citicoline sodium","Citicoline sodium salt","IP 302 SODIUM","IP-302 SODIUM"],"crossReferences":{"PubChem":["144206990","855585"]},"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL128136","canonicalSmiles":"C[S@@+]([O-])CCCCN=C=S","inchiKey":"SUVMJBTUFCVSAD-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL128136","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217652"],"drugbank":["DB12422"],"chEBI":["47808"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1296","canonicalSmiles":"CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1","inchiKey":"QYQDKDWGWDOFFU-IUODEOHRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOTIAM","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefotiam","Ceradon","J01DC07"],"crossReferences":{"Wikipedia":["Cefotiam"],"drugbank":["DB00229"],"chEBI":["355510"]},"childChemblIds":["CHEMBL4303232","CHEMBL1200589"],"count":1,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988 and is indicated for bacterial disease."}
{"id":"CHEMBL1321154","canonicalSmiles":"O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O","inchiKey":"XMVJITFPVVRMHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROXARSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112265","124882145","144203953","144208663","144213159","170465666","26748242","56463154"],"drugbank":["DB11458"],"chEBI":["35817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1322675","canonicalSmiles":"CCCNC[C@H](O)COc1ccccc1C(=O)CCc1ccccc1","inchiKey":"JWHAUXFOSRPERK-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1322675","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111634","11111635","11112738","50100315","50111221"],"drugbank":["DB15410"]},"childChemblIds":["CHEMBL1256654"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1325863","canonicalSmiles":"CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@H](Cn1c2nc(=O)[nH]c(=O)c-2nc2cc(C)c(C)cc21)OC(=O)CCC","inchiKey":"MJNIWUJSIGSWKK-BBANNHEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1325863","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206329","50125897"],"drugbank":["DB14727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL135287","canonicalSmiles":"CC1=C(CCCCCC(=O)O)C(=O)c2ccccc2C1=O","inchiKey":"ICGRXHWXPCXIKM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL135287","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1374069","canonicalSmiles":"OC1OC[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"SRBFZHDQGSBBOR-CZBDKTQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1374069","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217854"],"drugbank":["DB03911"],"chEBI":["59275"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL143324","canonicalSmiles":"CS(=N)(=O)CC[C@H](N)C(=O)O","inchiKey":"SXTAYKAGBXMACB-DPVSGNNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL143324","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50106626"],"drugbank":["DB14103"],"chEBI":["28490"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1475252","canonicalSmiles":"COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2n1","inchiKey":"ZBFDAUIVDSSISP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENATOPRAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tenatoprazole"],"crossReferences":{"PubChem":["144206071","170465931","50112774"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1493","canonicalSmiles":"Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O","inchiKey":"SPIUTQOUKAMGCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLAVOXATE","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flavoxate"],"crossReferences":{"DailyMed":["flavoxate%20hydrochloride"],"PubChem":["11112543"],"Wikipedia":["Flavoxate"],"drugbank":["DB01148"],"chEBI":["5088"]},"childChemblIds":["CHEMBL1200875"],"count":2,"approvedIndications":["HP_0000020","HP_0000103"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000171408","ENSG00000205268","ENSG00000113231","ENSG00000073417","ENSG00000184588"],"count":8},"linkedDiseases":{"rows":["HP_0000020","EFO_0003843","HP_0000103"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for polyuria and urinary incontinence."}
{"id":"CHEMBL1508","canonicalSmiles":"CN(C)CCC[C@@]1(c2ccc(F)cc2)OCc2cc(C#N)ccc21","inchiKey":"WSEQXVZVJXJVFP-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ESCITALOPRAM","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cipralex"],"synonyms":["Escitalopram","LU-26-054"],"crossReferences":{"DailyMed":["escitalopram%20oxalate"],"PubChem":["11110983","11114081","124879737","50100207"],"Wikipedia":["Escitalopram"],"drugbank":["DB01175"],"chEBI":["36791"]},"childChemblIds":["CHEMBL1200322"],"count":26,"approvedIndications":["MONDO_0002050","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","EFO_0004262","EFO_0005687","MONDO_0002009","MONDO_0004169","EFO_0000555","HP_0000726","EFO_0000249","EFO_0007453","EFO_1001919","EFO_1001917","EFO_0008568","EFO_0004698","EFO_0003829","MONDO_0002046","HP_0100543","EFO_0000289","MONDO_0002050","EFO_1001375","EFO_0000712","EFO_0003884","EFO_0003761","MONDO_0001162","EFO_0003047","EFO_0004242","EFO_0005230","EFO_0000692","MONDO_0005149","EFO_0006788","HP_0012076","EFO_0001645","EFO_1001908","EFO_0009963","EFO_0000313","EFO_0001358","HP_0002381","EFO_0009867","EFO_0003843","EFO_0000660","EFO_0000311","EFO_1001892","EFO_0008623","MONDO_0002491","EFO_0010282","EFO_0003890","EFO_1000781","EFO_0005411"],"count":47},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and is indicated for unipolar depression and depressive disorder and has 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1517","canonicalSmiles":"CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12","inchiKey":"IWVCMVBTMGNXQD-PXOLEDIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYTETRACYCLINE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Berkmycen","Chemocycline","Galenomycin","Hi-Tet","Imperacin","Microtet","OXTC","Oxymycin","Oxytetramix-250","Terramycin","Tetraplex","Unimycin"],"synonyms":["E703","NSC-9169","Oxitetracycline","Oxytetracycline","Oxytetracycline dihydrate","Terrafungine"],"crossReferences":{"PubChem":["144212697"],"Wikipedia":["Oxytetracycline"],"drugbank":["DB00595"],"chEBI":["27701"]},"childChemblIds":["CHEMBL3989568","CHEMBL1892210","CHEMBL1607480"],"count":4,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for bacterial disease and eye infection and has 2 investigational indications."}
{"id":"CHEMBL152","canonicalSmiles":"Nc1ccn(C[C@@H](CO)OCP(=O)(O)O)c(=O)n1","inchiKey":"VWFCHDSQECPREK-LURJTMIESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CIDOFOVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cidofovir","Vistide"],"synonyms":["Cidofovir","GS-0504","Vistide"],"crossReferences":{"DailyMed":["cidofovir"],"PubChem":["144206546"],"Wikipedia":["Cidofovir"],"drugbank":["DB00369"],"chEBI":["3696"]},"count":10,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for viral disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL153585","canonicalSmiles":"CC(C)NCC(O)COc1cccc2c1C=CC2","inchiKey":"MPGBPFMOOXKQRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDENOLOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indenolol","Indenolol hydrochloride","SCH 28316Z"],"crossReferences":{"DrugCentral":["1436"],"drugbank":["DB08952"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1569","canonicalSmiles":"Cl.NC12CC3CC(CC(C3)C1)C2","inchiKey":"WOLHOYHSEKDWQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMANTADINE HYDROCHLORIDE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL660","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amantadine hydrochloride","Gocovri","Lysovir","Mantadine","Osmolex er","Symadine","Symmetrel"],"synonyms":["Adamantanamine hydrochloride","Amantadine hydrochloride","EXP-105-1","NSC-83653"],"crossReferences":{"DailyMed":["amantadine%20hydrochloride"],"PubChem":["26747411","26747412","50105719","50105720"],"chEBI":["2619"]},"count":12,"approvedIndications":["EFO_1001175","EFO_0000544","EFO_0002508","EFO_1001402","EFO_0007328","EFO_1000860"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0003885","EFO_1001175","EFO_0004247","EFO_0000544","EFO_0002508","EFO_1001402","EFO_1000632","EFO_0007328","EFO_0003047","MONDO_0043510","EFO_0005411","EFO_1000860","EFO_0000692"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and has 6 approved and 6 investigational indications."}
{"id":"CHEMBL15770","canonicalSmiles":"CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\\c1ccc([S+](C)[O-])cc1","inchiKey":"MLKXDPUZXIRXEP-MFOYZWKCSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SULINDAC","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clinoril","Sulindac"],"synonyms":["MK-231","Sulindac"],"crossReferences":{"DailyMed":["sulindac"],"PubChem":["11111823","11111824","11114189","124881496","144203821","144211735","170464648","26732639","50106970","85231236","90341400"],"TG-GATEs":["100"],"Wikipedia":["Sulindac"],"drugbank":["DB00605"],"chEBI":["9352"]},"count":10,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["MONDO_0007608","Orphanet_733","EFO_0000389","MONDO_0007254","MONDO_0021074","EFO_0004142","EFO_0000222","EFO_0000181","EFO_0005755","EFO_1001951"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for rheumatic disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1583","canonicalSmiles":"CCOC(=O)OC(C)OC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C","inchiKey":"PFOLLRNADZZWEX-FFGRCDKISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BACAMPICILLIN","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bacampicillin"],"crossReferences":{"Wikipedia":["Bacampicillin"],"drugbank":["DB01602"],"chEBI":["2968"]},"childChemblIds":["CHEMBL1200965"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1587228","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"GGXMRPUKBWXVHE-MIHLVHIWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOMETASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Halometasone"],"crossReferences":{"PubChem":["26719837"],"drugbank":["DB13728"]},"childChemblIds":["CHEMBL2360244"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL159226","canonicalSmiles":"CC(=O)Oc1cc(C(C)C)c(OCCN(C)C)cc1C","inchiKey":"VRYMTAVOXVTQEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOXISYLYTE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1993},"tradeNames":["Erecnos","Moxivig"],"synonyms":["Acetoxythymoxamine","Moxisylyte","Moxisylyte hydrochloride","Thymoxamine"],"crossReferences":{"PubChem":["11111464","11111465","90340735"],"TG-GATEs":["61"],"drugbank":["DB09205"]},"childChemblIds":["CHEMBL1256739"],"count":2,"approvedIndications":["EFO_0004234","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000150594"],"count":6},"linkedDiseases":{"rows":["EFO_0004234","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for erectile dysfunction and cardiovascular disease. It was withdrawn in France  in 1993 due to Hepatotoxicity."}
{"id":"CHEMBL1605","canonicalSmiles":"Nc1nc(/C(=C/CC(=O)O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=CCS[C@H]23)cs1","inchiKey":"UNJFKXSSGBWRBZ-BJCIPQKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTIBUTEN","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cedax","Seftem"],"synonyms":["7432-S","ACHN-383","ACHN383","Ceftibuten","Ceftibuten dihydrate","SCH 39720","SCH-39720"],"crossReferences":{"DailyMed":["ceftibuten%20dihydrate"],"PubChem":["144204999"],"Wikipedia":["Ceftibuten"],"drugbank":["DB01415"],"chEBI":["3510"]},"count":3,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL1628233","canonicalSmiles":"O=C([O-])c1ccccc1-c1c2ccc(=O)cc-2oc2cc([O-])ccc12.[Na+].[Na+]","inchiKey":"NJDNXYGOVLYJHP-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORESCEIN SODIUM","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297067","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ak-Fluor","Fluor-amps","Fluorescite","Fluorets","Funduscein","Funduscein-25","Retinofluor"],"synonyms":["Fluorescein disodium salt","Fluorescein sodium","Fluorescein, soluble","Uranin"],"crossReferences":{"DailyMed":["fluorescein%20sodium"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 investigational indications."}
{"id":"CHEMBL1650443","canonicalSmiles":"Cn1c(=O)cc(N2CCC[C@@H](N)C2)n(Cc2cc(F)ccc2C#N)c1=O","inchiKey":"IWYJYHUNXVAVAA-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRELAGLIPTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SYR-472","Trelagliptin"],"crossReferences":{"drugbank":["DB15323"]},"childChemblIds":["CHEMBL1650457","CHEMBL2105754","CHEMBL1650456"],"count":1,"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_0001360","EFO_0000400"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1688243","canonicalSmiles":"CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C","inchiKey":"ZMCJFJZOSKEMOM-DNKZPPIMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INCB-9471","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-009471","INCB009471","INCB9471","Incb-9471"],"crossReferences":{"drugbank":["DB12960"]},"count":1,"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1698","canonicalSmiles":"CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1.Cl","inchiKey":"HEYVINCGKDONRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUPROPION HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL894","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bupropion hydrochloride","Forfivo xl","Wellbutrin","Wellbutrin 100","Wellbutrin 75","Wellbutrin sr","Wellbutrin xl","Zyban"],"synonyms":["Amfebutamone hydrochloride","BW 323","BW-323","Bupropion HCl","Bupropion hydrochloride","NSC-315851"],"crossReferences":{"DailyMed":["bupropion%20hydrochloride"],"PubChem":["144204172","144212161","170464747","26747451","49681824","50105906","573995","855813"]},"count":11,"approvedIndications":["MONDO_0002050","MONDO_0002009","EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319"],"count":2},"linkedDiseases":{"rows":["EFO_0004319","EFO_0005203","MONDO_0002009","Orphanet_905","EFO_0003768","EFO_0009963","EFO_0000313","EFO_0001073","EFO_0004318","EFO_0003829","EFO_0004247","EFO_0000289","MONDO_0002050","MONDO_0002491","MONDO_0008903","EFO_0003761"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743016","drugType":"Antibody","blackBoxWarning":false,"name":"FARLETUZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Farletuzumab","M3","MORAb-003"],"count":5,"linkedTargets":{"rows":["ENSG00000110195"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0002158","EFO_1001100","EFO_0000571","MONDO_0008170","EFO_0008516"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1743260","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CC[Si](C)(C)C)cccc3nc2-1","inchiKey":"SYXGVIWFCCQOEK-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KARENITECIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Karenitecin"],"count":6,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL1794791","canonicalSmiles":"O=C(O)CC(=O)C(=O)O","inchiKey":"KHPXUQMNIQBQEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXALOACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous enol-oxaloacetate","Oxaloacetate","Oxaloacetic acid"],"crossReferences":{"PubChem":["144208413"],"chEBI":["30744"]},"childChemblIds":["CHEMBL3950828"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1808388","canonicalSmiles":"OC[C@H]1O[C@@H](c2ccc(Cl)c(Cc3ccc(OCCOC4CC4)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"BTCRKOKVYTVOLU-SJSRKZJXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEXAGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bexagliflozin","EGT-0001442","EGT-1442","EGT0001442","EGT1442","THR-1442","THR1442"],"crossReferences":{"drugbank":["DB12236"]},"count":3,"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_1002032","EFO_0001360","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1817709","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCC(N)=O)NC1=O","inchiKey":"JCVQBJTWWDYUFQ-MRUTUVJXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SELEPRESSIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FE 202158","FE-202158","FE202158","Fe-202158","Selepressin"],"crossReferences":{"drugbank":["DB12495"]},"count":1,"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["EFO_0006834"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1868702","canonicalSmiles":"C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21CC","inchiKey":"BJJXHLWLUDYTGC-ANULTFPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTRINONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dimetriose"],"synonyms":["A 46 745","Gestrinone","R 2323","RU 2323"],"crossReferences":{"PubChem":["144206014","170466364","50112711"],"drugbank":["DB11619"],"chEBI":["89642"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1908397","canonicalSmiles":"O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1","inchiKey":"YYLKKYCXAOBSRM-JXMROGBWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KW-2449","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KW-2449","Kw 2449","Kw-2449"],"count":1,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000097007","ENSG00000178999","ENSG00000122025"],"count":4},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL197","canonicalSmiles":"COc1ccc(CCN(C)CCC[C@](C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC","inchiKey":"SGTNSNPWRIOYBX-HHHXNRCGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXVERAPAMIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexverapamil"],"crossReferences":{"PubChem":["26751824","26755233","50104517"],"drugbank":["DB14063"],"chEBI":["77734"]},"childChemblIds":["CHEMBL1994739","CHEMBL570489"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2096650","canonicalSmiles":"O.O.O.O.O.O=S([O-])([O-])=S.[Na+].[Na+]","inchiKey":"PODWXQQNRWNDGD-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM THIOSULFATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1208642","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ametox","Sodium thiosulfate","Sodothiol","Sulfothiorine"],"synonyms":["DB-020","Db-020","E539","NSC-45624","Sodium thiosulfate","Sodium thiosulfate hydrate","Sodium thiosulfate pentahydrate"],"crossReferences":{"DailyMed":["sodium%20thiosulfate"],"DrugCentral":["4518"],"chEBI":["32150"]},"count":10,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 10 investigational indications."}
{"id":"CHEMBL2103751","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCCc1ccc(N(CCCl)CCCl)cc1","inchiKey":"HFVNWDWLWUCIHC-GUPDPFMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNIMUSTINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LEO-1031","NSC-134087","NSC-171345","Prednimustine"],"crossReferences":{"drugbank":["DB12832"],"chEBI":["82524"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103794","canonicalSmiles":"CN(C)N(C)C(=O)[C@@]1(Cc2ccccc2)CCCN(C(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(C)(C)N)C1.Cl","inchiKey":"VFYAEUWJFGTGGO-GHTUPXNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANAMORELIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110579","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anamorelin hydrochloride","Ono-7643","RC-1291 HCl"],"count":2,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["HP_0004326","HP_0012378"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2103959","canonicalSmiles":"C[C@H]1O[C@@H](O[C@H]2[C@@H](OC=O)C[C@H](O[C@H]3[C@@H](OC=O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)[C@@H](OC=O)C[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](OC=O)[C@@H]1OC=O","inchiKey":"DOMHWKQEPDYUQX-LJAQBGIBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GITOFORMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gitoformate"],"crossReferences":{"drugbank":["DB13537"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104783","canonicalSmiles":"COCC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I","inchiKey":"IUNJANQVIJDFTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOPENTOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CPD. 5411","Iopentol"],"crossReferences":{"drugbank":["DB13861"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105555","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)[C@@H]1c1cccc([N+](=O)[O-])c1","inchiKey":"QZVNQOLPLYWLHQ-ZEQKJWHPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENIDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09231"]},"childChemblIds":["CHEMBL2359165"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105581","canonicalSmiles":"C=CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)cc(OC)c1OC","inchiKey":"RYJXBGGBZJGVQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERALIPRIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Spain"],"classes":["Dermatological toxicity"," Neurotoxicity"," Psychiatric toxicity"],"year":2005},"tradeNames":["Agreal"],"synonyms":["Veralipride"],"crossReferences":{"PubChem":["144205502"],"drugbank":["DB13523"]},"count":1,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979 and is indicated for psychosis. It was withdrawn in Spain  in 2005 due to Dermatological toxicity,  Neurotoxicity and  Psychiatric toxicity."}
{"id":"CHEMBL2105631","canonicalSmiles":"CC[C@H](C)OC(=O)Cc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1","inchiKey":"ZXOSVKYCXLTVGS-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUDIODARONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-2042","Budiodarone"],"crossReferences":{"drugbank":["DB05519"]},"childChemblIds":["CHEMBL2105632"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106403","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"XOEUHCONYHZURQ-HNUBZJOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURITHROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flurithromycin"],"crossReferences":{"drugbank":["DB13338"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107386","canonicalSmiles":"CCOC(=O)N[C@@H]1CC[C@@H]2[C@@H](C1)C[C@H]1C(=O)O[C@H](C)[C@H]1[C@H]2/C=C/c1ccc(-c2cccc(F)c2)cn1.O=S(=O)(O)O","inchiKey":"NQRYCIGCIAWEIC-CKLVGUEFSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORAPAXAR SULFATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL493982","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zontivity"],"synonyms":["SCH 530348","SCH-530348","Vorapaxar sulfate"],"crossReferences":{"DailyMed":["vorapaxar%20sulfate"],"chEBI":["83314"]},"count":4,"approvedIndications":["EFO_0000712","EFO_0000612","EFO_0004265"],"linkedTargets":{"rows":["ENSG00000181104"],"count":1},"linkedDiseases":{"rows":["EFO_0000712","EFO_0000612","EFO_0005672","EFO_0004265"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107387","canonicalSmiles":"Br.Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1","inchiKey":"VNGRUFUIHGGOOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORTIOXETINE HYDROBROMIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2104993","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Trintellix"],"synonyms":["Lu AA21004 (HBr)","Vortioxetine hydrobromide"],"crossReferences":{"DailyMed":["vortioxetine%20hydrobromide"],"chEBI":["76015"]},"count":1,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000108576","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2013 and is indicated for unipolar depression. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2107771","canonicalSmiles":"C[C@H](NCc1ccc(OCc2ccccc2F)cc1)C(N)=O","inchiKey":"BHJIBOFHEFDSAU-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALFINAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FCE-26742A","Nw-1029","PNU-0154339E","Priralfinamide","Ralfinamide"],"crossReferences":{"drugbank":["DB06649"]},"count":2,"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000136546","ENSG00000069535","ENSG00000148408","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000161509","ENSG00000185313","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000176884","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107861","drugType":"Antibody","blackBoxWarning":false,"name":"ZALUTUMUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2F8","HUMAX-EGFR, 2F8","HUMAX-EGFR-2F8","HuMax-EGFr","Zalutumumab"],"count":5,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0006859","EFO_0004284","EFO_0000707","EFO_0003060","EFO_1001951"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108046","drugType":"Cell","blackBoxWarning":false,"name":"REMESTEMCEL-L","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Prochymal"],"synonyms":["JR-0301","Remestemcel","Remestemcel-l"],"count":3,"description":"Cell drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108354","drugType":"Antibody","blackBoxWarning":false,"name":"UBLITUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TG-1101","Ublituximab"],"count":8,"linkedTargets":{"rows":["ENSG00000156738"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0003885","EFO_0000096","EFO_0000095","EFO_0000403","EFO_0004256","EFO_0003929","MONDO_0018906","EFO_1001469"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2108592","drugType":"Antibody","blackBoxWarning":false,"name":"EPITUMOMAB CITUXETAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Epitumomab cituxetan"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109303","drugType":"Antibody","blackBoxWarning":false,"name":"AVP-21D9","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVP-21D9","AVP21D9","Avp-21d9"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109458","drugType":"Antibody","blackBoxWarning":false,"name":"AMG-108","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-108","Amg-108"],"count":3,"linkedTargets":{"rows":["ENSG00000115594"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0002506","EFO_0000400"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110781","canonicalSmiles":"Cc1ccccc1CN1CCN(CCOC(c2ccccc2)c2ccccc2Cl)CC1","inchiKey":"VEVSKUJZSMGTMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORBENZOXAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorbenzoxamine"],"crossReferences":{"drugbank":["DB13788"]},"childChemblIds":["CHEMBL3989550"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111112","canonicalSmiles":"COc1ccc(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)cc1OC","inchiKey":"VBHQKCBVWWUUKN-KZNAEPCWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERNAKALANT","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Vernakalant"],"crossReferences":{"drugbank":["DB06217"]},"childChemblIds":["CHEMBL2107383"],"count":3,"approvedIndications":["EFO_0004269"],"linkedTargets":{"rows":["ENSG00000183873","ENSG00000055118","ENSG00000162989","ENSG00000130037","ENSG00000120457","ENSG00000171385"],"count":6},"linkedDiseases":{"rows":["EFO_0003911","EFO_0000275","EFO_0004269"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cardiac arrhythmia and has 2 investigational indications."}
{"id":"CHEMBL2152922","canonicalSmiles":"OC1(CN2CCC(COc3noc4cccc(O[C@@H]5CCOC5)c34)CC2)CCOCC1","inchiKey":"WLLOFQROROXOMO-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04995274","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04995274"],"crossReferences":{"drugbank":["DB12675"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2165615","canonicalSmiles":"Cc1cnc(NC(=O)c2cc(Oc3cnc(C(=O)N(C)C)nc3)c3cc(C)oc3c2)cn1","inchiKey":"MASKQITXHVYVFL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04937319","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04937319","Pf-04937319"],"crossReferences":{"drugbank":["DB15009"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2177913","canonicalSmiles":"NC1=N[C@@](c2cccc(-c3cncnc3)c2)(c2ccnc(C(F)F)c2)c2cccc(F)c21","inchiKey":"MRXBCEQZNKUUIP-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3839","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD3839","Azd 3839","Azd-3839","Azd3839"],"crossReferences":{"drugbank":["DB12368"]},"childChemblIds":["CHEMBL3542290","CHEMBL3542259"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2178953","canonicalSmiles":"Cc1nc(C)c(-c2ccc([C@H]3CC[C@H](CC(=O)O)CC3)cc2)nc1C(N)=O","inchiKey":"YXFNPRHZMOGREC-SHTZXODSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2178953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14949"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218394","canonicalSmiles":"CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C","inchiKey":"LHHCSNFAOIFYRV-DOVBMPENSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BOCEPREVIR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Victrelis"],"synonyms":["Boceprevir","EBP 520","EBP-520","SCH 503034","SCH-503034"],"crossReferences":{"Wikipedia":["Boceprevir"],"drugbank":["DB08873"],"chEBI":["68621"]},"count":5,"approvedIndications":["EFO_0004220","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for chronic hepatitis c virus infection and viral disease and has 3 investigational indications."}
{"id":"CHEMBL225071","canonicalSmiles":"Cc1nc(=O)c2cc(CN(C)c3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)s3)ccc2[nH]1","inchiKey":"IVTVGDXNLFLDRM-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALTITREXED","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tomudex"],"synonyms":["Raltitrexed","ZD-16","ZD-1694","ZD1694"],"crossReferences":{"PubChem":["144205790","144207198","49681782","499545"],"Wikipedia":["Raltitrexed"],"drugbank":["DB00293"],"chEBI":["5847"]},"count":12,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000176890"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","EFO_0005922","EFO_0000365","EFO_1000657","EFO_0005842","MONDO_0007576","MONDO_0000870","EFO_0004252","EFO_1001951","MONDO_0001056","EFO_1001480","EFO_0000588","EFO_0000330","EFO_0000707","EFO_0000181"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for neoplasm and has 11 investigational indications."}
{"id":"CHEMBL237337","canonicalSmiles":"CN(C)C(=O)[C@@H](c1ccc(-c2ccc3ncnn3c2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1","inchiKey":"ZNHVIJAGMFQGMS-IHPCNDPISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL237337","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08504"]},"childChemblIds":["CHEMBL377221"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL237500","canonicalSmiles":"CC#CCn1c(N2CCC[C@@H](N)C2)nc2c1c(=O)n(Cc1nc(C)c3ccccc3n1)c(=O)n2C","inchiKey":"LTXREWYXXSTFRX-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LINAGLIPTIN","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tradjenta","Trajenta"],"synonyms":["BI 1356","BI 1356 BS","BI-1356","BI-1356-BS","BI-1356BS","BS 1356 BS","BS-1356-BS","Linagliptin"],"crossReferences":{"DailyMed":["linagliptin"],"Wikipedia":["Linagliptin"],"drugbank":["DB08882"],"chEBI":["68610"]},"count":10,"approvedIndications":["EFO_0001360","EFO_0000400"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["HP_0000083","MONDO_0100096","EFO_0000684","EFO_0002916","EFO_0000503","EFO_0004997","MONDO_0003219","EFO_0001360","EFO_0000400","EFO_0000692","EFO_0003060","EFO_0000537"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for diabetes mellitus and type ii diabetes mellitus and has 8 investigational indications."}
{"id":"CHEMBL2386595","canonicalSmiles":"[2H]C([2H])([2H])N1CCN(Cc2ccc(C(=O)Nc3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc2)CC1","inchiKey":"KTUFNOKKBVMGRW-BMSJAHLVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2386595","maximumClinicalTrialPhase":0,"parentId":"CHEMBL941","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2393130","canonicalSmiles":"COc1cc(OC)c2c(=O)[nH]c(-c3cc(C)c(OCCO)c(C)c3)nc2c1","inchiKey":"NETXMUIMUZJUTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APABETALONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Apabetalone","RVX-000222","RVX-208","RVX000222"],"crossReferences":{"drugbank":["DB12000"]},"count":4,"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0001361","Orphanet_324","EFO_0001645","EFO_0003884","EFO_0000400"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2396661","canonicalSmiles":"Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1","inchiKey":"STUWGJZDJHPWGZ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPELISIB","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Piqray"],"synonyms":["Alpelisib","BYL-719","Byl-719","NVP-BYL719"],"crossReferences":{"DailyMed":["alpelisib"],"drugbank":["DB12015"]},"count":16,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000121879"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001931","EFO_0003869","EFO_0002618","EFO_0005922","EFO_1000616","EFO_0000186","Orphanet_44890","MONDO_0007254","EFO_1000657","EFO_0000305","MONDO_0044704","EFO_1001951","MONDO_0001056","EFO_0001421","EFO_0004284","EFO_0009146","EFO_0001378","Orphanet_2495","EFO_0000707","EFO_0000181"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 4 approved and 12 investigational indications."}
{"id":"CHEMBL244243","canonicalSmiles":"C[C@@H](NC(=O)[C@@H](CC(=O)N1CCC(N2CCCCC2)CC1)N1C(=O)[C@@H](N2C(=O)OC[C@@H]2c2ccccc2)[C@H]1/C=C/c1ccccc1)c1cccc(C(F)(F)F)c1","inchiKey":"ZPKHVQNRKMCYGL-AFAPVMNMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SRX246","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Srx246"],"count":3,"linkedTargets":{"rows":["ENSG00000166148"],"count":1},"linkedDiseases":{"rows":["Orphanet_399","EFO_0004247","EFO_0001358","EFO_0005230"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL252967","canonicalSmiles":"CCCn1c(C2CCN(C)CC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CC2)n1","inchiKey":"XCTKFTOEAKJMII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL252967","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03084"],"chEBI":["47188"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253359","canonicalSmiles":"Cc1cc(-c2nc3ccccc3o2)cc(C)c1O","inchiKey":"NORYHCMDDBZXDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL253359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL253376","canonicalSmiles":"CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1","inchiKey":"OJGDCBLYJGHCIH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMHEXINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bromhexine"],"crossReferences":{"PubChem":["174006813"],"Wikipedia":["Bromhexine"],"drugbank":["DB09019"],"chEBI":["77032"]},"childChemblIds":["CHEMBL1319139"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL258202","canonicalSmiles":"CC[C@@H](C)Nc1ncc(C(=O)Nc2cc(C(=O)NC)ccc2C)s1","inchiKey":"OYOUIHFZUAKCEF-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-640994","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-640994"],"crossReferences":{"drugbank":["DB06991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL260629","canonicalSmiles":"N=C(NO)NCCC[C@H](N)C(=O)O","inchiKey":"FQWRAVYMZULPNK-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL260629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111278"],"drugbank":["DB03144"],"chEBI":["43088"]},"childChemblIds":["CHEMBL1256282"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL273158","canonicalSmiles":"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1","inchiKey":"FOHZGCHKLPIBBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL273158","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL274323","canonicalSmiles":"N[C@@H](CC(=O)O)C(=O)O","inchiKey":"CKLJMWTZIZZHCS-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARTIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspartic acid","FEMA NO. 3656","L-aspartic acid","NSC-3973"],"crossReferences":{"PubChem":["11113409","26751648","50104339","90340967"],"drugbank":["DB00128"],"chEBI":["17053"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL28885","canonicalSmiles":"N[C@@H](COS(=O)(=O)O)C(=O)O","inchiKey":"LFZGUGJDVUUGLK-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-Serine O-Sulfate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Serine O-Sulfate","Serine O-Sulfate"],"crossReferences":{"drugbank":["DB03497"],"chEBI":["15829"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL290194","canonicalSmiles":"C=CCN1CCCC1CNC(=O)c1cc2nn[nH]c2cc1OC","inchiKey":"KSEYRUGYKHXGFW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALIZAPRIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alizapride","Litican","Plitican","Superan","Vergentan"],"crossReferences":{"Wikipedia":["Alizapride"],"drugbank":["DB01425"]},"childChemblIds":["CHEMBL1896987"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL29741","canonicalSmiles":"CN(C)CCOc1ccccc1-c1nc(-c2ccccc2)no1","inchiKey":"QZULPCPLWGCGSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IRAMPANEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIR 561","BIIR-561","BIIR-561 CL","Irampanel"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL29898","canonicalSmiles":"O=C1c2ccc(O)c(O)c2C(=O)c2c(O)ccc(O)c21","inchiKey":"VBHKTXLEJZIDJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINALIZARIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,2,5,8-Tetrahydroxy-Anthraquinone","Quinalizarin"],"crossReferences":{"PubChem":["26749241","538929"],"Wikipedia":["Quinalizarin"],"drugbank":["DB08660"],"chEBI":["37495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3138647","canonicalSmiles":"C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1.I","inchiKey":"GNYRFSRGJVIYQB-NMRUWYRNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3138647","maximumClinicalTrialPhase":0,"parentId":"CHEMBL412873","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182532","canonicalSmiles":"CCCCCCOc1cc(C)c(O)c(C)c1C","inchiKey":"ATMNQRRJNBCQJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HX-1171","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hx-1171"],"crossReferences":{"PubChem":["144211562"],"drugbank":["DB12162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186422","canonicalSmiles":"CCCCCC[C@@H](O)C/C=C\\CCCCCCCC(=O)O","inchiKey":"WBHHMMIMDMUBKC-QJWNTBNXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186422","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206956","144211415"],"drugbank":["DB02955"],"chEBI":["28592"]},"childChemblIds":["CHEMBL3186755"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL326564","canonicalSmiles":"CCCCn1c(Cc2ccc3c(c2)OCO3)nc2c(N)ncnc21","inchiKey":"JCDXXNIRWRRGBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL326564","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08436"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301600","canonicalSmiles":"C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1.O=S(=O)(O)c1ccccc1","inchiKey":"ABSXPNGWJFAPRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPEBRUTINIB BESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3301625","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AVL-292","AVL-292 BESYLATE","CC-292","CC-292 BESYLATE","Spebrutinib","Spebrutinib besilate","Spebrutinib besylate"],"count":3,"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_0000685","EFO_0000403"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301601","canonicalSmiles":"CN1C(=N)N[C@](C)(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)CS1(=O)=O","inchiKey":"YHYKUSGACIYRML-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VERUBECESTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8931","SCH 900931","SCH-900931","SCH900931","Verubecestat"],"crossReferences":{"drugbank":["DB12285"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3301622","canonicalSmiles":"CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1","inchiKey":"GYQYAJJFPNQOOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GILTERITINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASP-2215","ASP2215","Asp-2215","Gilteritinib"],"crossReferences":{"DailyMed":["gilteritinib%20fumarate"],"drugbank":["DB12141"]},"childChemblIds":["CHEMBL3301603","CHEMBL4524472"],"count":6,"approvedIndications":["EFO_0000616"],"linkedTargets":{"rows":["ENSG00000167601","ENSG00000122025"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0019457","EFO_0001421","EFO_1000131","EFO_0000222","EFO_0003060"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neoplasm and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3301626","canonicalSmiles":"Cc1nc(C#Cc2ccnc(Cl)c2)c(C)n1-c1ccc(F)cc1","inchiKey":"UPZWINBEAHDTLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BASIMGLURANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Basimglurant","RG-7090","RO-4917523","RO4917523","Rg7090"],"crossReferences":{"drugbank":["DB11833"]},"count":3,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","Orphanet_908"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3301845","canonicalSmiles":"CC(CCc1ccc2c(c1)OCO2)NN","inchiKey":"IBWPUTAKVGZXRB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAFRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB09253"]},"childChemblIds":["CHEMBL3186177"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL334491","canonicalSmiles":"CC(C)(C)N1CCC(c2ccccc2)(c2ccccc2)CC1","inchiKey":"QIHLUZAFSSMXHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUDIPINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Budipine"],"crossReferences":{"Wikipedia":["Budipine"],"drugbank":["DB13502"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL33986","canonicalSmiles":"Oc1ccc2c(c1)[C@@]13CCCC[C@@]1(O)[C@@H](C2)N(CC1CCC1)CC3","inchiKey":"IFKLAQQSCNILHL-QHAWAJNXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUTORPHANOL","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butorphanol","LEVO-BC-2627"],"crossReferences":{"DailyMed":["butorphanol%20tartrate"],"Wikipedia":["Butorphanol"],"chEBI":["3242"]},"childChemblIds":["CHEMBL299400"],"count":2,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000082556","ENSG00000112038"],"count":2},"linkedDiseases":{"rows":["EFO_0005230","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for pain and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545079","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-5622","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Plx-5622"],"count":1,"linkedTargets":{"rows":["ENSG00000182578"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545163","canonicalSmiles":"CCNC(=O)[C@H]1CC(n2ccc3c(NC(CC)Cc4sccc4Cl)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"CKQOOYMMAAPDKH-NXKGBEFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMP579","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amp579","RPR-100579"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545295","drugType":"Small molecule","blackBoxWarning":false,"name":"AVE0847","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ave0847"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL356700","canonicalSmiles":"NCC1CCN(CC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2C2CCCCC2)CC1","inchiKey":"AITZHKQVQNLKHI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL356700","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07618"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3639788","canonicalSmiles":"O=C(Cc1cccc(OC(F)(F)F)c1)Nc1ccc(CCCCc2nnc(NC(=O)Cc3ccccn3)s2)nn1","inchiKey":"PRAAPINBUWJLGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TELAGLENASTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CB-839","Telaglenastat"],"crossReferences":{"drugbank":["DB15232"]},"childChemblIds":["CHEMBL4594286"],"count":10,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3707210","name":"CHEMBL3707210","tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11342"]}}
{"id":"CHEMBL3707219","canonicalSmiles":"COC(=O)c1ccc(OC(=O)CCCCCCC(=O)NO)cc1","inchiKey":"XDZAHHULFQIBFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REMETINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Remetinostat","SHP-141"],"crossReferences":{"drugbank":["DB14869"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3707234","canonicalSmiles":"O=C(NC(Cc1ccccc1)c1ccccc1)c1cccnc1","inchiKey":"DWODOIKZDGJOPQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NICOFETAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nicofetamide"],"crossReferences":{"drugbank":["DB13531"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL376408","canonicalSmiles":"CN(C)CC[C@H](CSc1ccccc1)Nc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2)cc1[N+](=O)[O-]","inchiKey":"HPLNQCPCUACXLM-PGUFJCEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT 737","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-737","Abt 737"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3765320","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)[O-])cn(C3CC3)c12.[K+]","inchiKey":"CPIRAFYCGJZVNW-DFIJPDEKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3765320","maximumClinicalTrialPhase":0,"parentId":"CHEMBL32","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL380888","canonicalSmiles":"Oc1cc(O)c(-c2[nH]ncc2N2CCNCC2)cc1Cl","inchiKey":"RFPHEBUOQYYPDO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL380888","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07100"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833306","drugType":"Antibody","blackBoxWarning":false,"name":"VANDORTUZUMAB VEDOTIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSTP3086S","MSTP2109A","RG-7450","RG7450","Vandortuzumab vedotin"],"count":1,"linkedTargets":{"rows":["ENSG00000164647"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL383923","canonicalSmiles":"O=c1cc(O)n([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"UDOBICLZEKUKCV-YXZULKJRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"6-hydroxy-UMP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-hydroxy-UMP"],"crossReferences":{"drugbank":["DB02890"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3910844","canonicalSmiles":"[2H]c1c([2H])c(N(C)c2nc(C)nc3ccccc23)c([2H])c([2H])c1OC","inchiKey":"SNHCRNMVYDHVDT-OCFVFILASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3910844","maximumClinicalTrialPhase":0,"parentId":"CHEMBL492399","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL395280","canonicalSmiles":"C/C=C1\\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2","inchiKey":"ZRJBHWIHUMBLCN-YQEJDHNASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395280","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205156","170466837"],"Wikipedia":["Huperzine_A"],"drugbank":["DB04864"],"chEBI":["78330"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989432","canonicalSmiles":"CC(=O)CC/C=C(/C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C.CC(=O)CC/C=C(\\C)CC/C=C(\\C)CC/C=C(\\C)CCC=C(C)C","inchiKey":"DJAHKBBSJCDSOZ-AJLBTXRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEPRENONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-0671","Teprenone"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3989511","canonicalSmiles":"N=C(N)NCc1cccc([131I])c1.N=C(N)NCc1cccc([131I])c1.O=S(=O)(O)O","inchiKey":"XNACDNPGABUBFR-GNPGNDBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE SULFATE I 131","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Iobenguane sulfate i 131"],"synonyms":["Iobenguane sulfate i 131","Iobenguane sulfate i-131","M131ibg"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994."}
{"id":"CHEMBL3989629","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.O.O=S(=O)(O)O","inchiKey":"SMWLLNMVQNVPLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIZATRIPTAN SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL905","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-A462","Rizatriptan sulfate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989826","canonicalSmiles":"COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314.O=C(O)c1ccc(C(=O)O)cc1","inchiKey":"BTEYIHUKHHAVAN-KDKWOIFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYCODONE TEREPHTHALATE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL656","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxycodone terephthalate"],"crossReferences":{"DailyMed":["oxycodone%20terephthalate"]},"count":1,"approvedIndications":["EFO_0003843"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1950 and is indicated for pain."}
{"id":"CHEMBL3989856","canonicalSmiles":"O.O.O.O.O.O.O.O.O.O.O=S(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"RSIJVJUOQBWMIM-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM SULFATE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL233406","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glaubers Salt","Golytely"],"synonyms":["Glauber's salt","Sodium sulfate","Sodium sulfate anhydrous","Sodium sulfate, dried"],"crossReferences":{"DailyMed":["sodium%20sulfate%20anhydrous"]},"count":1,"approvedIndications":["HP_0002019"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and is indicated for constipation."}
{"id":"CHEMBL3989956","canonicalSmiles":"CC(=O)O.COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)COC(=O)CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1","inchiKey":"KNFBFAYGLUSKNV-GOXRTRPTSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ZOPTARELIN DOXORUBICIN ACETATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3544954","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEZS-108","AN-52","D-81858","ZEN-008","Zoptarelin doxorubicin acetate"],"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4070364","canonicalSmiles":"CNC(C)C(=O)c1ccccc1","inchiKey":"LPLLVINFLBSFRP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4070364","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15339"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL418971","canonicalSmiles":"CC(C)(c1ccc(O)cc1)c1ccc(O)cc1","inchiKey":"IISBACLAFKSPIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BISPHENOL A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124890224","144210190","144214049","17389142","17390010","26752849","49718108","92277586"],"Wikipedia":["Bisphenol_A"],"drugbank":["DB06973"],"chEBI":["33216"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297363","canonicalSmiles":"CCOC(=O)[C@H](Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=C(Br)C(=O)C12CCCCC2","inchiKey":"QCYAXXZCQKMTMO-QFIPXVFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UCB-1184197","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDP-323","CDP323","Cdp323","Ucb-1184197"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297434","canonicalSmiles":"CC(C)(CS(=O)(=O)[O-])N(Cl)Cl.O.[Na+]","inchiKey":"DZYCRLINOCERBD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AURICLOSENE MONOSODIUM MONOHYDRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1207907","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-46383A","Auriclosene monosodium monohydrate","Sodium 2-(dichloroamino)-2-methylpropane-1-sulfonate monohydrate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297457","canonicalSmiles":"CC(C)(O)c1cccn2c(C3(c4ccc(Cl)cc4)CC3)nnc12.Cl","inchiKey":"MQBBSMNIRWXALO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-823778","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4301600","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-823778","Bms-823778"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297481","canonicalSmiles":"Cn1ncc2cc(-c3cc(CCC(=O)O)cc(N)c3OC3Cc4ccccc4C3)ccc21","inchiKey":"ULNYPYSSPODXCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AK-106","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AK-106","AK106","AK106-001616","Ak-106","Ak106-001616"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297648","canonicalSmiles":"[O-][n+]1cccc(-c2nc3c(Cl)cccc3cc2[C@@H](Nc2ncnc3cccnc23)C(F)(F)F)c1","inchiKey":"LNLJHGXOFYUARS-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELETALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Seletalisib","UCB-5857","UCB5857","Ucb5857"],"crossReferences":{"drugbank":["DB12706"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297657","canonicalSmiles":"CC(=O)O.CCc1cc2c(cc1CC)CC(NC[C@H](O)c1ccc(O)c3[nH]c(=O)ccc13)C2","inchiKey":"HZHXFIDENGBQFQ-FTBISJDPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDACATEROL ACETATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1095777","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indacaterol acetate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297693","drugType":"Unknown","blackBoxWarning":false,"name":"AMP-110","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMP-110","Amp-110"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297722","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CEMDISIRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cemdisiran"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297725","drugType":"Unknown","blackBoxWarning":false,"name":"CHLORINE DIOXIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlorine dioxide"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297782","drugType":"Unknown","blackBoxWarning":false,"name":"MINNELIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Minnelide"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297864","drugType":"Antibody","blackBoxWarning":false,"name":"CENDAKIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-308","Abt-308","CC-93538","Cendakimab","RPC-4046"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297910","drugType":"Unknown","blackBoxWarning":false,"name":"ARTEMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Artemin","BG-00010","BG00010","Bg00010"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297930","drugType":"Unknown","blackBoxWarning":false,"name":"CYC-065","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyc-065","Cyc065","Fadraciclib"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298054","drugType":"Unknown","blackBoxWarning":false,"name":"STEM BROMELAIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromelain stem bromelain","Escharex","Nexobrid","Stem bromelain"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4298105","drugType":"Protein","blackBoxWarning":false,"name":"VALZIFLOCEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SHP-652","SHP652","SM-101","SM101","Sm101","Valziflocept"],"count":1,"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298158","canonicalSmiles":"CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1.O=C(O)/C=C/C(=O)O","inchiKey":"LUEMEFHVOJNLJG-WLHGVMLRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ONVANSERTIB FUMARATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1738758","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Onvansertib fumarate","PMS-075H"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL431210","canonicalSmiles":"CCCC[C@H](CN(O)C=O)C(=O)N[C@H](C(=O)N(C)C)C(C)(C)C","inchiKey":"AVDLWYHBABSSHC-CHWSQXEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BB-3497","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BB-3497"],"crossReferences":{"drugbank":["DB04368"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453716","canonicalSmiles":"C1COCCO1","inchiKey":"RYHBNJHYFVUHQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIOXANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1,4-Dioxane"],"crossReferences":{"PubChem":["144208169"],"Wikipedia":["1,4-Dioxane"],"drugbank":["DB03316"],"chEBI":["47032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456218","canonicalSmiles":"COc1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1F","inchiKey":"TUTZKAQTSPMEBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456218","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07014"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459008","canonicalSmiles":"CCCCOC(=O)c1ccc(O)cc1","inchiKey":"QFOHBWFCKVYLES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTYLPARABEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyl p-hydroxybenzoate","Butyl parahydroxybenzoate","Butylparaben"],"crossReferences":{"PubChem":["104171292","11112246","144203944","144208983","144210650","170465688","17390002","22405509","26752916"],"Wikipedia":["Butylparaben"],"drugbank":["DB14084"],"chEBI":["88542"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594363","drugType":"Unknown","blackBoxWarning":false,"name":"IRGD","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEND-1","Cend-1","Irgd"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594399","canonicalSmiles":"[2H]C([2H])([2H])C(O)(CCC[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3/C[C@@H](O)CCC3=C)CCC[C@@]21C)C([2H])([2H])[2H]","inchiKey":"JWUBBDSIWDLEOM-QFVHMXLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D6-25-HYDROXYVITAMIN D3","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1040","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D6-25-hydroxyvitamin d3"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594407","canonicalSmiles":"CCCCCCCCC=CCCCCCCCC(=O)OCC1COP(=O)(O)C1","inchiKey":"PUPWWTUVIZOPTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBACYCLIC PHOSPHATIDIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2ccpa","Carbacyclic phosphatidic acid"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594591","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-1400","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-1400","REGN1400","Regn-1400","Regn1400"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594597","drugType":"Unknown","blackBoxWarning":false,"name":"REGN-5678","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-5678","REGN5678","Regn-5678","Regn5678"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL460","canonicalSmiles":"CCc1c(C)[nH]c2c1C(=O)C(CN1CCOCC1)CC2","inchiKey":"KLPWJLBORRMFGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOLINDONE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Moban","Molindone"],"crossReferences":{"DailyMed":["molindone%20hydrochloride"],"PubChem":["26755691","50111112","90341242"],"Wikipedia":["Molindone"],"drugbank":["DB01618"],"chEBI":["6965"]},"childChemblIds":["CHEMBL1200419"],"count":2,"approvedIndications":["EFO_0005407"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005407","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for psychosis and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL468154","canonicalSmiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"CDAISMWEOUEBRE-CDRYSYESSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCYLLITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-103","Cyclohexane-1,2,3,4,5,6-Hexaol","ELND-005","ELND005","Scyllitol","Scyllo-Inositol"],"crossReferences":{"drugbank":["DB03106"],"chEBI":["10642"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL480329","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C[C@H]1O","inchiKey":"NLIHPCYXRYQPSD-BAJZRUMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3'-dATP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-dATP"],"crossReferences":{"drugbank":["DB01860"],"chEBI":["52316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL481611","canonicalSmiles":"CC(C)(F)C[C@H](N[C@@H](c1ccc(-c2ccc(S(C)(=O)=O)cc2)cc1)C(F)(F)F)C(=O)NC1(C#N)CC1","inchiKey":"FWIVDMJALNEADT-SFTDATJTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODANACATIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0822","MK0822","Odanacatib"],"crossReferences":{"Wikipedia":["Odanacatib"],"drugbank":["DB06670"]},"count":6,"linkedTargets":{"rows":["ENSG00000143387"],"count":1},"linkedDiseases":{"rows":["HP_0000083","EFO_0002506","EFO_0003854","MONDO_0007254","EFO_0003882","MONDO_0008315"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL484726","canonicalSmiles":"Cc1c(/N=C2\\O[C@@H](C(F)(F)F)[C@@H]3[C@@H](O)CCN23)ccc(C#N)c1Cl","inchiKey":"KALFKWQLCWAXJO-RNSKTZJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL484726","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08088"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50267","canonicalSmiles":"O=C(O)c1cc(O)c2c(Cl)cc(Cl)cc2n1","inchiKey":"BGKFPRIGXAVYNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5,7-Dichlorokynurenic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5,7-Dichlorokynurenic Acid"],"crossReferences":{"PubChem":["11111036","11113436","124879827","26747105","26751671","50104367","90341603"],"drugbank":["DB01931"]},"childChemblIds":["CHEMBL1731625"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL508583","canonicalSmiles":"CC(C)[C@@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@H](NCCCNCCCCNCCCN)C[C@@H]1C[C@H]3O)OS(=O)(=O)O","inchiKey":"WUJVPODXELZABP-FWJXURDUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRODUSQUEMINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MSI-1436","Trodusquemine"],"crossReferences":{"drugbank":["DB06333"]},"childChemblIds":["CHEMBL2028167","CHEMBL2386602"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL509101","canonicalSmiles":"O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O","inchiKey":"OBSFXHDOLBYWRJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509101","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["174006560"],"drugbank":["DB06896"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL522891","canonicalSmiles":"O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1","inchiKey":"FPKSFXFWECAIBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL522891","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08066"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL540531","canonicalSmiles":"CCCCCCCC/N=C(N)/N=C(\\N)NCc1ccc(Cl)c(Cl)c1.Cl","inchiKey":"GVBQOBUYEOFFLD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLANEXIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1190262","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL549473","canonicalSmiles":"[O-][n+]1ccccc1SSc1cccc[n+]1[O-]","inchiKey":"ZHDBTKPXEJDTTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRITHIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dipyrithione","OMDS"],"crossReferences":{"PubChem":["144205684","170465699","26757912"],"drugbank":["DB11327"]},"childChemblIds":["CHEMBL2106674"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550936","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(N=[N+]=[N-])O[C@@H](n2ccc(N)nc2=O)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C","inchiKey":"VKXWOLCNTHXCLF-DXEZIKHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BALAPIRAVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Balapiravir","RO-4588161","RO4588161"],"crossReferences":{"drugbank":["DB12283"]},"childChemblIds":["CHEMBL2105678"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL550961","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CN1C(=O)c2cccc(O)c2Nc2c(O)cc(O)cc21","inchiKey":"SALVHVNECODMJP-GNUCVDFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIAZEPINOMICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amo-01","BU-4664L","Diazepinomicin","ECO-4601","TLN-4601"],"crossReferences":{"drugbank":["DB12420"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL559401","canonicalSmiles":"Cc1ccc(C(=O)NC2CC2)cc1Nc1cc(=O)n(C)c2c1cnn2-c1ccc(F)cc1F","inchiKey":"WMEYCLAVMZKZCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL559401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08349"],"chEBI":["82714"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL573819","canonicalSmiles":"O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl","inchiKey":"FCADPEDUULETPK-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL573819","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590753","canonicalSmiles":"Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CC2CC2)n1","inchiKey":"DFEYXQGDDCDXJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-218655","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SB-218655"],"crossReferences":{"drugbank":["DB03980"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL592868","canonicalSmiles":"CC#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C","inchiKey":"GJUHUIXJLZINMA-MJCUULBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTROGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estrogen"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL609109","canonicalSmiles":"CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1","inchiKey":"VZYCZNZBPPHOFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPROPERAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thioproperazine"],"crossReferences":{"Wikipedia":["Thioproperazine"],"drugbank":["DB01622"],"chEBI":["59120"]},"childChemblIds":["CHEMBL1481539","CHEMBL1406487"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL64676","canonicalSmiles":"CC(C)COc1cccc(-c2nc3cc(C(=N)N)ccc3[nH]2)c1O","inchiKey":"HSHVHNIOQTZSOQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL64676","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04470"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL688","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"IVLVTNPOHDFFCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FENTANYL CITRATE","yearOfFirstApproval":1968,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL596","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Abstral","Actiq","Fentanyl","Fentanyl citrate","Fentanyl citrate preservative free","Fentora","Lazanda","Onsolis","Sublimaze","Sublimaze preservative free","Thalamonal"],"synonyms":["Fentanyl citrate","Fentanyl citrate cii","MCN-JR-4263-49","R-4263"],"crossReferences":{"DailyMed":["fentanyl%20citrate"],"chEBI":["31602"]},"count":9,"approvedIndications":["EFO_0003843","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","HP_0002094","EFO_0009508","EFO_1001139","HP_0012532","EFO_0003843","EFO_0000311","EFO_0000546","EFO_0009727","HP_0100543","HP_0002045","EFO_0003841","EFO_0004244","HP_0003419","EFO_0000341"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1968 and is indicated for pain and cancer and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL7492","canonicalSmiles":"COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1","inchiKey":"VJXSSYDSOJBUAV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRITREXIM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BW-301U","Piritrexim","TCMDC-137235"],"crossReferences":{"drugbank":["DB03695"]},"childChemblIds":["CHEMBL1712863"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL84242","canonicalSmiles":"OC(O)(C(F)(F)F)C(F)(F)F","inchiKey":"AKVXSYUWYXOLMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL84242","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02922"]},"childChemblIds":["CHEMBL1989577"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL886","canonicalSmiles":"O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)cc1F","inchiKey":"HFEKDTCAMMOLQP-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"5-FLUORODEOXYURIDYLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-Fluoro-2-Deoxyuridine Monophosphate (Fdump)"],"crossReferences":{"drugbank":["DB03761"],"chEBI":["2129"]},"childChemblIds":["CHEMBL1823492"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL925","canonicalSmiles":"N[C@@H](Cc1ccc(O)cc1)C(=O)O","inchiKey":"OUYCCCASQSFEME-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TYROSINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["FEMA NO. 3736","L-tyrosine","Levodopa impurity, l-tyrosine-","Levodopa related compound l-tyrosine","NSC-82624","Tyrosine"],"crossReferences":{"PubChem":["144205147","170466853","29215265"],"Wikipedia":["Tyrosine"],"drugbank":["DB00135"],"chEBI":["17895"]},"count":3,"approvedIndications":["EFO_0001360"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for type ii diabetes mellitus and has 2 investigational indications."}
{"id":"CHEMBL956","canonicalSmiles":"CC(C(=O)O)c1ccc(C(=O)c2cccs2)cc1","inchiKey":"MDKGKXOCJGEUJW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUPROFEN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"," United Kingdom"," Spain"],"classes":["Musculoskeletal toxicity"," Nephrotoxicity"],"year":1987},"tradeNames":["Profenal"],"synonyms":["R-25,061","R-25061","Suprofen","Sutoprofen"],"crossReferences":{"PubChem":["144204194","170465412","26748525","56463227"],"Wikipedia":["Suprofen"],"drugbank":["DB00870"],"chEBI":["9362"]},"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and is indicated for rheumatic disease. It was withdrawn in United States,  United Kingdom and  Spain initially in 1987 due to Musculoskeletal toxicity and  Nephrotoxicity."}
{"id":"CHEMBL971","canonicalSmiles":"CCCC(C)C1(CC)C(=O)[N-]C(=O)NC1=O.[Na+]","inchiKey":"QGMRQYFBGABWDR-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTOBARBITAL SODIUM","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL448","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Norway"],"classes":["Misuse"],"year":1980},"tradeNames":["Beuthanasia","Euthanase","Euthatal","Nembutal","Nembutal sodium","Pentobarbital sodium","Pentobarbitone Sodium","Sagatal","Sodium pentobarbital"],"synonyms":["Pentobarbital sodium"],"crossReferences":{"DailyMed":["pentobarbital%20sodium"],"chEBI":["7984"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1973. It was withdrawn in Norway  in 1980 due to Misuse."}
